SNR - #1 Healthcare Investment - 6.8% Yield And 25% Upside
When you think of healthcare investments, you may first think of highly innovative biotech companies such as Gilead (GILD), Amgen (AMGN) or Celgene (CELG) with highly exciting products and the chance to earn outsized returns on capital.
While we agree that such “hot and popular” sectors are exciting, we are much less certain about their future return generation potential. A new product breakthrough or innovation may cause the stock of a biotech company to skyrocket, but its failure may also cause it to plummet. The volatility is